New oral migraine drug called Amerge

    You'll see a new oral migraine drug called Amerge. Glaxo is introducing it now in the U.S....a little later in Canada.

    Amerge (naratriptan) is similar to Imitrex (sumatriptan)...except Amerge is longer-acting.

    This means fewer recurrent headaches with Amerge than with Imitrex. About 40% of patients using Imitrex have recurrent headaches because of its short half-life.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote